A 61-year old male was operated with a 25 mm Biocor (St Jude Medical, St Paul, MN) aortic bioprosthesis in 2001. In 2017 the patient developed dyspnoea. Echocardiography revealed severe transvalvular regurgitation.In January 2018 a TAVI (Transcatheter Aortic Valve Implantation) valve-in-valve procedure was performed using a 23 mm ACURATE neo prosthesis (Boston Scientific, Marlborough, MA) (Panel A). The prosthesis was postdilated with a 22 mm balloon. Postoperative and 30-day echocardiography was unremarkable.
2. Karolinska University Hospital, Department of Cardiology, Stockholm, Sweden
3. Karolinska University Hospital, Department of Cardiology, Stockholm, Sweden
4. Karolinska University Hospital, Department of Cardiology, Stockholm, Sweden
As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention - has been published immediately upon acceptance as it was received. The content of this article is the sole responsibility of the authors, and not that of the journal or its publishers.
To read the full content of this article, please download the PDF. Download full article (PDF)
Sign in to read and download the full articleForgot your password?
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com